Federal contract award

75A50124C00023

KARIUS, INC. R&D FOR METAGENOMIC SEQUENCING OF MICROBIAL CELL-FREE DNA AND RNA FOR COMPREHENSIVE PATHOGEN DETECTION AOI #26 AGNOSTIC DIAGNOSTIC

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN15 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$631.0K
Current contract value$631.0K
Potential contract value / ceiling$631.0K
Start dateJul 1, 2024
Current end dateJan 9, 2026
Potential end dateJan 9, 2026
Latest award activityAug 5, 2025
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 5, 2025P00004$0THE PURPOSE OF THIS NO COST MODIFICATION IS TO UPDATE SECTION G.1 CONTRACTING OFFICER FROM HUNTER WILLIAMS TO AUDREY GLOVER.
Apr 22, 2025P00003$0KARIUS, INC. R&D FOR METAGENOMIC SEQUENCING OF MICROBIAL CELL-FREE DNA AND RNA FOR COMPREHENSIVE PATHOGEN DETECTION AOI #26 AGNOSTIC DIAGNOSTIC
Nov 25, 2024P00002$0KARIUS, INC. R&D FOR METAGENOMIC SEQUENCING OF MICROBIAL CELL-FREE DNA AND RNA FOR COMPREHENSIVE PATHOGEN DETECTION AOI #26 AGNOSTIC DIAGNOSTIC
Jul 2, 2024P00001$-118.9KKARIUS, INC. R&D FOR METAGENOMIC SEQUENCING OF MICROBIAL CELL-FREE DNA AND RNA FOR COMPREHENSIVE PATHOGEN DETECTION AOI #26 AGNOSTIC DIAGNOSTIC
Jun 20, 20240$749.9KKARIUS, INC. R&D FOR METAGENOMIC SEQUENCING OF MICROBIAL CELL-FREE DNA AND RNA FOR COMPREHENSIVE PATHOGEN DETECTION AOI #26 AGNOSTIC DIAGNOSTIC

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.